NewRal is Matricelf's investigational personalized neural tissue transplant being developed for patients with traumatic spinal cord injury. The FDA feedback was provided through a Written Response ...

Three Pennsylvania youth football coaches were charged Thursday, days after they were part of a massive brawl caught on video ...

Eighty-two thousand fewer Hoosiers are receiving benefits through the Supplemental Nutrition Assistance Program since ...

Ultragenyx plunges 46% after its phase III Angelman syndrome study fails to achieve key efficacy goals, putting apazunersen's future in question.

From a $99,900 jet-powered speeder bike to a $39,900 aircraft that folds into a pickup truck, a new generation of personal ...

Silicon Motion Technology Corporation (NasdaqGS: SIMO), a global leader in designing and marketing NAND flash controllers for solid-state storage devices, today announced that it has completed the ...

The Voting Rights Project at UCLA files a lawsuit to stop Americans' personal data from being swept up by the federal ...

Matricelf Ltd. (MTLF), a regenerative medicine company, announced that it has received written feedback from the U.S. FDA supporting key elements of its proposed first in human clinical trial of ...

How the process is going for officials in Nebraska and Montana could provide key lessons for states facing a Jan. 1 deadline, including Wisconsin.

Paramount Skydance (PSKY) stock gained 4% as New Jersey Democrats urged their AG to drop the merger lawsuit and court filings ...

Capricor Therapeutics, Inc. downgraded to Hold after FDA panel setback for deramiocel in DMD. Click for this CAPR stock ...

At the annual State of the Region, professionals from the transit, transportation, military and defense sectors gathered to ...